PMID: 42014715

Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.

Van Lier Pip M G, van de Weijer Tineke, Vanweert Froukje, Brouwers Kim, Nijssen Kevin M R, Schaart Gert, Moonen-Kornips Esther, van Beek Sten M M, Springer Sam, Wierts Roel

Nature communications · 2026

Vol. 17, Issue 1

View on PubMed DOI

This entry links to third-party literature. For research use only.

AdultAgedFemaleHumansMaleMiddle AgedAdipose Tissue, BrownAdrenergic beta-2 Receptor AgonistsClenbuterolCross-Over Studies

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.

Prolonged &#x3b2;2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.

Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.